awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q30315301-F3D6405D-08CA-4108-A6C7-6E22A6EA7954
Q30315301-F3D6405D-08CA-4108-A6C7-6E22A6EA7954
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30315301-F3D6405D-08CA-4108-A6C7-6E22A6EA7954
ABC3 Consensus: Assessment by a German Group of Experts
P2860
Q30315301-F3D6405D-08CA-4108-A6C7-6E22A6EA7954
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30315301-F3D6405D-08CA-4108-A6C7-6E22A6EA7954
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
18ec22c656a58709614deaed87cf1bcc5531d05f
P2860
A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS).